4Y7-14441-84533
1 vaccination
3 coded responses
3 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 117 / NY
- Registered
- 2021-05-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-29
Dose 1 — Pfizer-BioNTech
-
2021-05-08
Registered in v-safe
-
2021-05-08
Survey response — day 35, dose 1MedDRA: Hospitalisation, Neurological symptom — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, HospitalizationFree text: Adverse neurological symptoms since the first vaccine, resulted in 2 hospital stays. Was advised by both not to go back for the 2nd vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-08
Report sent to call center — day 35, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-10
Survey response — day 42, dose 1MedDRA: Arthralgia, Balance disorder, Chest pain, Fatigue, Loss of personal independence in daily activities, Mastication disorder, Mobility decreased, Muscle spasms, Myalgia, Paraesthesia, Speech disorder, Vision blurred — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, HospitalizationFree text: Extreme fatigue, muscle/joint pain, pins & needles in arms/legs, blurred vision/off balance, spasms, chest pain. Speech/chewing difficulty. Cannot do daily activities/climb stairs. Told by hospital(s) not to get 2nd vaccine due to adverse reaction.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-10
Report sent to call center — day 42, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-08
-
2021-06-28
Survey response — 3 months, dose 1MedDRA: Neurological symptom, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, HospitalizationFree text: Symptoms: Continued neurological problems · Healthcare visit (other): In AprilMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-28
Report sent to call center — 3 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-01
-
2022-02-28
Call successfulReported to VAERS voluntarily prior to GDIT contact
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-29 | Pfizer-BioNTech |
Call center
3 call center cases
3 successful
VAERS report filed, before or during a call: 3
Free text
Release 8 — day 35, dose 1
Symptoms: Adverse neurological symptoms since the first vaccine, resulted in 2 hospital stays. Was advised by both not to go back for the 2nd vaccine.
Release 8 — day 42, dose 1
Symptoms: Extreme fatigue, muscle/joint pain, pins & needles in arms/legs, blurred vision/off balance, spasms, chest pain. Speech/chewing difficulty. Cannot do daily activities/climb stairs. Told by hospital(s) not to get 2nd vaccine due to adverse reaction. cut off by CDC
Release 9 — 3 months, dose 1
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Balance disorder | ✓ | ✓ | ✓ |
| SD | Chest pain | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hospitalisation | ✓ | ✓ | ✓ |
| SD | Loss of personal independence in daily activities | ✓ | ✓ | ✓ |
| SD | Mastication disorder | ✓ | ✓ | ✓ |
| SD | Mobility decreased | ✓ | ✓ | ✓ |
| SD | Muscle spasms | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Neurological symptom | ✓ | ✓ | ✓ |
| SD | Paraesthesia | ✓ | ✓ | ✓ |
| SD | Speech disorder | ✓ | ✓ | ✓ |
| SD | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release